A Phase IB Study of Vaccination with Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Human Granulocyte-Macrophage Stimulating Factor.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs GM-CSF-transduced tumour cell vaccine (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 27 Jan 2021 Biomarkers information updated
- 12 Jun 2013 Planned end date changed from 1 Jun 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 08 Aug 2012 Planned end date changed from 1 Jan 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.